Sanofi SA
XHAM:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
Actia Group SA
F:AG9
|
FR |
|
C
|
China State Construction International Holdings Ltd
F:C4S1
|
HK |
|
N
|
New Stratus Energy Inc
F:80N
|
CA |
|
F
|
Fabasoft AG
XMUN:FAA
|
AT |
|
Ascencio SCA
LSE:0P2J
|
BE |
|
I
|
ID Logistics SAS
F:1ID
|
FR |
|
Mitsubishi Corp
F:MBI0
|
JP |
|
Altius Renewable Royalties Corp
TSX:ARR
|
CA |
|
A
|
Atalaya Mining PLC
TSX:AYM
|
CY |
|
Engie SA
PAR:ENGI
|
FR |
|
I
|
Intercontinental Exchange Inc
XETRA:IC2
|
US |
|
B
|
Bid Corporation Ltd
JSE:BID
|
ZA |
|
Sea Ltd
NYSE:SE
|
SG |
|
SoFi Technologies Inc
NASDAQ:SOFI
|
US |
|
R
|
ResGen Ltd
BSE:543805
|
IN |
|
P
|
Pfizer Inc
XMUN:PFE
|
US |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
93.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
620.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
139.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 13.8B EUR. This includes both short-term (0 EUR) and long-term (13.8B EUR) debt.
You can find a full breakdown on its Balance Sheet.
